QPPV.COM KNOWLEDGE ASSESSMENT

Scientific Writing in Pharmacovigilance: Knowledge Assessment

Test your understanding of the concepts covered by Scientific Writing in Pharmacovigilance.

Question 1 of 10Pass mark: 80%

Question 1 of 10 A medical writer includes a statement that an adverse event is caused by a medicine because that wording would support a desired risk-minimisation measure. Why is this inappropriate?

Risk-minimisation measures can never be based on scientific evaluations Scientific language should be selected according to the evidence, not anticipated regulatory outcomes Causality terminology is prohibited in all pharmacovigilance documents Regulatory documents should contain observations but no conclusions

Question 2 of 10 What is the primary purpose of scientific writing in a pharmacovigilance regulatory document?

To persuade regulators to accept the author's preferred conclusion To present evidence and reasoning so that independent reviewers can understand how conclusions were reached To provide the longest possible description of all available safety data To demonstrate that the organisation has followed its internal document template

Question 3 of 10 Which statement best reflects the article's position on the relationship between writing quality and evidence quality?

Strong writing can compensate for weak evidence if the reasoning is persuasive Weak writing proves that the underlying evidence is weak Clear writing can communicate the strength and limitations of evidence but cannot make weak evidence stronger Writing quality is relevant only to readability, not regulatory confidence

Question 4 of 10 Why is contradictory evidence important in a signal assessment?

It must always be treated as more reliable than supporting evidence It demonstrates that no conclusion can ever be reached Considering it helps show that the conclusion reflects the totality of evidence rather than selective reporting It should be included only when it supports the preferred regulatory action

Question 5 of 10 Which statement best describes the role of uncertainty in high-quality pharmacovigilance writing?

Uncertainty should be eliminated from the final document whenever possible Uncertainty should be communicated in proportion to limitations such as rare events, incomplete follow-up or conflicting findings Uncertainty should always lead to the most conservative regulatory action Uncertainty indicates that the available evidence has no value

Question 6 of 10 Why should observation and interpretation be presented separately in a pharmacovigilance document?

To ensure that medical judgement is removed from the document To allow readers to distinguish the factual evidence from the author's scientific assessment To prevent the use of any qualitative conclusions To make the document conform to academic publication conventions

Question 7 of 10 During medical review, an author discovers that new evidence has changed the interpretation presented earlier in the report. What is the most appropriate response?

Preserve the earlier interpretation to maintain superficial consistency Remove the new evidence so that all sections retain the original narrative Update the relevant sections and explain why the scientific narrative has changed Present both interpretations without indicating which one is currently supported

Question 8 of 10 A report states that a risk is absent solely because no regulatory action was taken. What is the fundamental problem with this reasoning?

Regulatory actions are always based only on spontaneous reports A regulatory decision is not itself scientific evidence about the existence or absence of a risk Regulatory decisions cannot address safety concerns The report should discuss only clinical trial data

Question 9 of 10 A reviewer can see the final conclusion but cannot determine which data were considered or why alternative explanations were rejected. Which principle is most directly unmet?

Proportionate writing Traceability and transparent explanation of reasoning Use of regulatory terminology Concise documentation of routine findings

Question 10 of 10 Which example best demonstrates traceability of a conclusion?

The report states that the risk is acceptable without citing supporting information The report links the conclusion to identified data, explains the assessment of competing explanations and shows how the conclusion informed the regulatory recommendation The report repeats the conclusion in several sections using stronger wording The report refers generally to the safety database without identifying the relevant analysis

Scientific Writing in Pharmacovigilance: Knowledge Assessment

Cookie Settings